Harm Reduction Group Past Earnings Performance
Past criteria checks 0/6
Harm Reduction Group's earnings have been declining at an average annual rate of -55.4%, while the Tobacco industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 65.2% per year.
Key information
-55.4%
Earnings growth rate
37.5%
EPS growth rate
| Tobacco Industry Growth | 9.2% |
| Revenue growth rate | 65.2% |
| Return on equity | -57.4% |
| Net Margin | -14.7% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
Harm Reduction Group AB (publ) (NGM:NOHARM) Might Not Be As Mispriced As It Looks After Plunging 25%
Apr 24
Market Cool On Harm Reduction Group AB (publ)'s (NGM:NOHARM) Revenues Pushing Shares 30% Lower
Mar 05Health Check: How Prudently Does Harm Reduction Group (NGM:NOHARM) Use Debt?
Feb 29Further Upside For Harm Reduction Group AB (publ) (NGM:NOHARM) Shares Could Introduce Price Risks After 32% Bounce
Jan 05It's Down 28% But Harm Reduction Group AB (NGM:NOHARM) Could Be Riskier Than It Looks
Sep 05Does Harm Reduction Group (NGM:NOHARM) Have A Healthy Balance Sheet?
Sep 01Companies Like SealWacs (NGM:SEAL) Are In A Position To Invest In Growth
Dec 28Revenue & Expenses BreakdownBeta
How Harm Reduction Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 169 | -25 | 77 | 0 |
| 30 Sep 23 | 174 | -21 | 83 | 0 |
| 30 Jun 23 | 177 | -21 | 83 | 0 |
| 31 Mar 23 | 180 | -13 | 80 | 0 |
| 31 Dec 22 | 178 | -11 | 78 | 0 |
| 30 Sep 22 | 154 | -11 | 63 | 0 |
| 30 Jun 22 | 122 | -11 | 51 | 0 |
| 31 Mar 22 | 118 | -12 | 37 | 0 |
| 31 Dec 21 | 80 | -11 | 21 | 0 |
| 30 Sep 21 | 29 | -8 | 11 | 0 |
| 30 Jun 21 | 25 | -5 | 4 | 0 |
| 31 Mar 21 | 0 | -2 | 2 | 0 |
| 31 Dec 20 | 0 | -2 | 2 | 0 |
| 30 Sep 20 | 28 | 0 | 2 | 0 |
| 30 Jun 20 | 15 | 0 | 1 | 0 |
| 31 Mar 20 | 0 | -1 | 1 | 0 |
| 31 Dec 19 | 0 | -1 | 1 | 0 |
| 30 Sep 19 | 0 | -2 | 2 | 0 |
| 30 Jun 19 | 0 | -2 | 2 | 0 |
| 31 Mar 19 | 0 | -3 | 3 | 0 |
| 31 Dec 18 | 0 | -3 | 3 | 0 |
| 30 Sep 18 | 0 | -2 | 2 | 0 |
| 30 Jun 18 | 0 | -2 | 2 | 0 |
| 31 Mar 18 | 0 | -2 | 2 | 0 |
| 31 Dec 17 | 0 | -2 | 2 | 0 |
| 30 Sep 17 | 0 | -3 | 3 | 0 |
| 30 Jun 17 | 0 | -3 | 3 | 0 |
| 31 Mar 17 | 0 | -3 | 3 | 0 |
| 31 Dec 16 | 0 | -3 | 3 | 0 |
| 30 Sep 16 | 0 | -2 | 2 | 0 |
| 30 Jun 16 | 0 | -2 | 2 | 0 |
| 31 Mar 16 | 0 | -2 | 2 | 0 |
| 31 Dec 15 | 0 | -2 | 2 | 0 |
| 30 Sep 15 | 0 | -1 | 1 | 0 |
| 30 Jun 15 | 0 | -1 | 1 | 0 |
| 31 Mar 15 | 0 | -1 | 1 | 0 |
| 31 Dec 14 | 0 | 0 | 0 | 0 |
| 30 Sep 14 | 0 | 0 | 0 | 0 |
Quality Earnings: NOHARM is currently unprofitable.
Growing Profit Margin: NOHARM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NOHARM is unprofitable, and losses have increased over the past 5 years at a rate of 55.4% per year.
Accelerating Growth: Unable to compare NOHARM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NOHARM is unprofitable, making it difficult to compare its past year earnings growth to the Tobacco industry (-0.1%).
Return on Equity
High ROE: NOHARM has a negative Return on Equity (-57.37%), as it is currently unprofitable.